Dow Jones

40 211,72

0,53%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
13/05/2021	17h14	PR Newswire (US)	Insmed Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes and Full Exercise of Underwriters' ...	NASDAQ:INSM	Insmed Inc
13/05/2021	13h47	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSM	Insmed Inc
12/05/2021	12h07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:INSM	Insmed Inc
11/05/2021	07h54	PR Newswire (US)	Insmed Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028	NASDAQ:INSM	Insmed Inc
10/05/2021	13h00	PR Newswire (US)	Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028	NASDAQ:INSM	Insmed Inc
07/05/2021	14h00	PR Newswire (US)	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
06/05/2021	13h31	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSM	Insmed Inc
06/05/2021	13h30	PR Newswire (US)	Insmed Reports First Quarter 2021 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
22/04/2021	14h00	PR Newswire (US)	Insmed to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021	NASDAQ:INSM	Insmed Inc
12/04/2021	19h07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:INSM	Insmed Inc
01/04/2021	22h30	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:INSM	Insmed Inc
29/03/2021	19h26	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:INSM	Insmed Inc
23/03/2021	10h00	PR Newswire (US)	ARIKAYCE® (amikacin liposome inhalation suspension) Approved by Japan's Ministry of Health, Labour and Welfare for the Treat...	NASDAQ:INSM	Insmed Inc
18/03/2021	21h23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
25/02/2021	13h30	PR Newswire (US)	Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
24/02/2021	14h00	PR Newswire (US)	Insmed to Present at Two March Conferences	NASDAQ:INSM	Insmed Inc
19/02/2021	13h30	PR Newswire (US)	Insmed Announces Topline Results from Phase 1 Study of Treprostinil Palmitil Inhalation Powder (TPIP)	NASDAQ:INSM	Insmed Inc
16/02/2021	14h00	PR Newswire (US)	Insmed to Host Conference Call to Discuss Topline Data from Treprostinil Palmitil Inhalation Powder Phase 1 Study	NASDAQ:INSM	Insmed Inc
12/02/2021	14h00	PR Newswire (US)	Insmed to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021	NASDAQ:INSM	Insmed Inc
05/01/2021	14h00	PR Newswire (US)	Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference	NASDAQ:INSM	Insmed Inc
04/01/2021	14h00	PR Newswire (US)	Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with M...	NASDAQ:INSM	Insmed Inc
02/12/2020	14h00	PR Newswire (US)	Insmed Announces Initiation of Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis	NASDAQ:INSM	Insmed Inc
24/11/2020	14h00	PR Newswire (US)	Insmed to Present at the Evercore ISI 3rd Annual HealthCONx Conference	NASDAQ:INSM	Insmed Inc
13/11/2020	14h00	PR Newswire (US)	Insmed Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Brensocatib in Patients with ...	NASDAQ:INSM	Insmed Inc
02/11/2020	14h00	PR Newswire (US)	Insmed to Present at Two November Conferences	NASDAQ:INSM	Insmed Inc
29/10/2020	12h30	PR Newswire (US)	Insmed Reports Third Quarter 2020 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
28/10/2020	12h37	PR Newswire (US)	European Commission Grants Marketing Authorization for ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion for the Treatment of ...	NASDAQ:INSM	Insmed Inc
20/10/2020	14h00	PR Newswire (US)	Insmed to Host Third Quarter 2020 Financial Results Conference Call on Thursday, October 29, 2020	NASDAQ:INSM	Insmed Inc
30/09/2020	14h00	PR Newswire (US)	Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D Day	NASDAQ:INSM	Insmed Inc
16/09/2020	14h00	PR Newswire (US)	Insmed to Host R&D Day on September 30, 2020	NASDAQ:INSM	Insmed Inc